Evidence map›Paper›PMID 22768027›Full record

ArticleTheranostics2012

Radio-deoxynucleoside Analogs used for Imaging tk Expression in a Transgenic Mouse Model of Induced Hepatocellular Carcinoma.

Haibin Tian, Xincheng Lu, Hong Guo, David Corn, Joseph Molter, Bingcheng Wang, Guangbin Luo, Zhenghong Lee

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Haibin Tian1. Departments of Radiology.
Xincheng Lu
Hong Guo
David Corn
Joseph Molter
Bingcheng Wang
Guangbin Luo
Zhenghong Lee
Case Western Reserve University · USCase Comprehensive Cancer CenterInstitut thématique Génétique, génomique et bioinformatique · FRPediatrics and Genetics · US

Funding

Quantitative FDG-PET for Imaging Woodchuck HCCR01CA095307 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LEE, ZHENGHONG · 2003 to 2013
$3.5M
EphA2 kinase in prostate cancerR01CA155676 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2011 to 2016
$1.6M
Akt-EphA2 Crosstalk in Glioma InvasionR01CA152371 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MIAO, HUI, WANG, BINGCHENG · 2010 to 2014
$1.6M
EphA2 Agonists as Novel Inhibitors of Tumor ProgressionR01CA092259 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2002 to 2007
$1.4M
Eph Kinase Signaling In Renal Epithelial CellsR01DK077876 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2008 to 2011
$1.4M
Northeastern Ohio Animal Imaging Resource Center- NOAIRCU24CA110943 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI DUERK, JEFFREY L. · 2007 to 2008
$1.3M
NCI NIH HHS R01 CA092259NCI NIH HHS R01 CA095307NCI NIH HHS R01 CA152371NCI NIH HHS R01 CA155676NCI NIH HHS U24 CA110943NIDDK NIH HHS R01 DK077876
6 · The paper itself

Abstract

purposeA group of radiolabeled thymidine analogs were developed as radio-tracers for imaging herpes viral thymidine kinase (HSV1-tk) or its variants used as reporter gene. A transgenic mouse model was created to express tk upon liver injury or naturally occurring hepatocellular carcinoma (HCC). The purpose of this study was to use this unique animal model for initial testing with radio-labeled thymidine analogs, mainly a pair of newly emerging nucleoside analogs, D-FMAU and L-FMAU.

methodsA transgeneic mouse model was created by putting a fused reporter gene system, firefly luciferase (luc) and HSV1-tk, under the control of mouse alpha fetoprotein (Afp) promoter. Initial multimodal imaging, which was consisted of bioluminescent imaging (BLI) and planar gamma scintigraphy with [(125)I]-FIAU, was used for examining the model creation in the new born and liver injury in the adult mice. Carcinogen diethylnitrosamine (DEN) was then administrated to induce HCC in these knock-in mice such that microPET imaging could be used to track the activity of Afp promoter during tumor development and progression by imaging tk expression first with [(18)F]-FHBG. Dynamic PET scans with D-[(18)F]-FMAU and L-[(18)F]-FMAU were then performed to evaluate this pair of relatively new tracers. Cells were derived from these liver tumors for uptake assays using H-3 labeled version of PET tracers.

resultsThe mouse model with dual reporters: HSV1-tk and luc placed under the transcriptional control of an endogenous Afp promoter was used for imaging studies. The expression of the Afp gene was highly specific in proliferative hepatocytes, in regenerative liver, and in developing fetal liver, and thus provided an excellent indicator for liver injury and cancer development in adult mice. Both D-FMAU and L-FMAU showed stable liver tumor uptake where the tk gene was expressed under the Afp promoter. The performance of this pair of tracers was slightly different in terms of signal-to-background ratio as well as tracer clearance.

conclusionThe newly created knock-in mouse model was used to demonstrate the use of the dual-reporter genes driven by well-characterized cancer-specific transcriptional units in conjunction with in vivo imaging as a paradigm in studying naturally occurring cancer in live animals. While BLI is suitable for small animal imaging with luc expression, PET with L-FMAU seemed be the choice for liver injury or liver cancer imaging with this animal model for future investigations.

Indexed as

deoxynucleoside analogshepatocellular carcinomareporter gene imaging

Identifiers

PMID22768027
PMCPMC3388592
OpenAlexW2125598581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.